Preview

Problems of Endocrinology

Advanced search

Evaluation of FreeStyle Libre in pediatric t1dm: improved glycemic control, reduction in diabetic ketoacidosis and severe hypoglycemia

https://doi.org/10.14341/probl12877

Abstract

BACKGROUND: Self-monitoring of blood glucose (SMBG) with glucometers provides only a snapshot of the glycemic profile and is accompanied by significant psychological discomfort and pain, especially in children. Flash Glucose Monitoring System — FreeStyle Libre (FSL) overcomes many of the barriers associated with glucose measurement and improves metabolic control.

AIM: To evaluate the efficacy of FSL in children with type 1 diabetes mellitus (T1DM) in terms of glycemic control, episodes of severe hypoglycemia (SH) and diabetic ketoacidosis (DKA).

MATERIALS AND METHODS. A multicenter, prospective, observational study in real clinical practice was carried out. A total of 469 subjects (258 boys and 211 girls) aged 4–18 were included in the study. The median age was 11.3 (8.4–14.6) years, duration of T1DM — 4.2 (2.1–7.1) years. After FSL start, patient was followed up for 6 months.

RESULTS: After 3 and 6 months of FSL use, HbA1c significantly decreased from 7.4% to 7.1% and 7.2%, respectively (p<0.001). The number of children with HbA1c ><7.5% increased from 51% to 60% and 58% at 3 and 6 months, respectively (p><0.001). The incidence of DKA and SH, as well as the proportion of patients experiencing at least one episode of DKA and SH, were significantly reduced after 6 months of FSL use compared with baseline (p><0.001).

CONCLUSION: The Study demonstrated a significant improvement in metabolic control in children with T1DM 6 months after FSL start: decrease in HbA1c, accompanied by reduction in incidence of DKA and SH.

About the Authors

D. N. Laptev
National Medical Research Center for Endocrinology
Russian Federation

Dmitry N. Laptev, PhD

Moscow


Competing Interests:

Автор декларирует отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.



O. B. Bezlepkina
National Medical Research Center for Endocrinology
Russian Federation

Olga B. Bezlepkina, PhD

Moscow


Competing Interests:

Автор декларирует отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.



E. S. Demina
Russian Children’s Clinical Hospital
Russian Federation

Elena S. Demina, PhD

Moscow


Competing Interests:

Автор декларирует отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.



O. A. Malievskiy
Bashkir State Medical University
Russian Federation

Oleg A. Malievskiy, PhD, professor

Ufa


Competing Interests:

Автор декларирует отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.



I. L. Nikitina
National Medical Research Center n.a. V. A. Almazov
Russian Federation

Irina L. Nikitina, professor, PhD

 St. Petersburg


Competing Interests:

Автор декларирует отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.



I. G. Samoilova
Siberian State Medical University
Russian Federation

Iuliia G. Samoilova, PhD, professor

Tomsk


Competing Interests:

Автор декларирует отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.



V. A. Peterkova
National Medical Research Center for Endocrinology
Russian Federation

Valentina A. Peterkova, PhD, professor, academician of RAS

Moscow


Competing Interests:

Автор декларирует отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.



References

1. Dedov II, Shestakova MV, Mayorov AYu, et al. Standards of specialized diabetes care. Diabetes Mellitus. 2019;22(S1):1-144 (In Russ.). doi: https://doi.org/10.14341/DM221S1.

2. Peterkova VA, Shestakova MV, Bezlepkina OB, et al. Diabetes mellitus type 1 in childhood. Diabetes mellitus. 2020;23(1S):4-40. (In Russ.). doi: https://doi.org/10.14341/DM12504.

3. Dedov II, Shestakova MV, Mayorov AY, et al. Diabetes mellitus type 1 in adults. Diabetes mellitus. 2020;23(1S):42-114. (In Russ.) doi: https://doi.org/10.14341/DM12505.

4. DiMeglio LA, Acerini CL, Codner E, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr Diabetes. 2018;19:105-114. doi: https://doi.org/10.1111/pedi.12737

5. Campbell FM, Murphy NP, Stewart C, et al. Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study. Pediatr Diabetes. 2018;19(7):1294-1301. doi: https://doi.org/10.1111/pedi.12735

6. Tauschmann M, Hermann JM, Freiberg C, et al. Reduction in Diabetic Ketoacidosis and Severe Hypoglycemia in Pediatric Type 1 Diabetes During the First Year of Continuous Glucose Monitoring: A Multicenter Analysis of 3,553 Subjects From the DPV Registry. Diabetes Care. 2020;43(3):e40-e42. doi: https://doi.org/10.2337/dc19-1358

7. Leiva-Gea I, García Vázquez J, Liñán Jurado FR, et al. Introduction of flash glucose monitoring in children with Type 1 diabetes: experience of a single-centre in Spain. ESPE Abstracts. 2019;92:LB-20.

8. Suzuki J, Urakami T, Yoshida K, et al. Association between scanning frequency of flash glucose monitoring and continuous glucose monitoring‐derived glycemic makers in children and adolescents with type 1 diabetes. Pediatr Int. 2021;63(2):154-159. doi: https://doi.org/10.1111/ped.14412

9. Messaaoui A, Tenoutasse S, Crenier L. Flash Glucose Monitoring Accepted in Daily Life of Children and Adolescents with Type 1 Diabetes and Reduction of Severe Hypoglycemia in Real-Life Use. Diabetes Technol Ther. 2019;21(6):329-335. doi: https://doi.org/10.1089/dia.2018.0339

10. Deeb A, Yousef H, Al Qahtani N, et al. Novel ambulatory glucosesensing technology improves hypoglycemia detection and patient monitoring adherence in children and adolescents with type 1 diabetes. J Diabetes Metab Disord. 2019;18(1):1-6. doi: https://doi.org/10.1007/s40200-018-0351-9

11. Al Hayek AA, Robert AA, Al Dawish MA. Evaluation of FreeStyle Libre Flash Glucose Monitoring System on Glycemic Control, HealthRelated Quality of Life, and Fear of Hypoglycemia in Patients with Type 1 Diabetes. Clin Med Insights Endocrinol Diabetes. 2017;10. doi: https://doi.org/10.1177/1179551417746957

12. Vergier J, Samper M, Dalla-Vale F, et al. Evaluation of flash glucose monitoring after long-term use: A pediatric survey. Prim Care Diabetes. 2019;13(1):63-70. doi: https://doi.org/10.1016/j.pcd.2018.08.004


Supplementary files

1. Рисунок 1. Показатели времени в диапазонах в зависимости от частоты сканирования датчика за сутки. ВЦД — время в целевом диапазоне 3,9–10 ммоль/л, ВВД — время выше целевого диапазона >10 ммоль/л, ВНД — время ниже целевого диапазона <3,9 ммоль/л. Данные представлены в виде: медиана (интерквартильный диапазон) и отдельные значения. Использован критерий Краскела–Уоллиса.
Subject
Type Исследовательские инструменты
View (512KB)    
Indexing metadata ▾
2. Рисунок 2. Уровень HbA1c в зависимости от частоты сканирования датчика за сутки. Данные представлены в виде: медиана (интерквартильный диапазон) и отдельные значения. Использован критерий Краскела–Уоллиса.
Subject
Type Исследовательские инструменты
View (208KB)    
Indexing metadata ▾

Review

For citations:


Laptev D.N., Bezlepkina O.B., Demina E.S., Malievskiy O.A., Nikitina I.L., Samoilova I.G., Peterkova V.A. Evaluation of FreeStyle Libre in pediatric t1dm: improved glycemic control, reduction in diabetic ketoacidosis and severe hypoglycemia. Problems of Endocrinology. 2022;68(3):86-92. (In Russ.) https://doi.org/10.14341/probl12877

Views: 2058


ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)